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The  plasma  membrane-located  murine  Ia  antigens  consist  of two  polymorphic 
chains: the larger chain, designated a, is ~35,000 mol wt, whereas the smaller chain, 
designated fi, is ~28,000 mol wt (1). Whereas the I-A antigens are encoded by genes 
(Aa and AO)  located within  the I-A  subregion, the  I-E antigens  are encoded by one 
gene (E~)  located in the I-E subregion and a  second (Ep or A,) 1 in the I-A subregion 
(2). 
Previous studies from our laboratories have used F1 hybrids to explore the serological 
(3,  4)  and  biochemical  (5)  basis  for the  complementation  between  the  E~  and  E# 
genes.  These studies,  which established  that complementation  could occur between 
the  genes involved in the trans  configuration,  provided evidence that  the structural 
genes for the a  and fl chains were the complementing genetic elements.  During the 
course  of the  biochemical  studies  (5),  we  compared  the  Ep  chain  derived  from  a 
(D2.GD  ×  A.TFR5)Fa  (A a, E b  ×  A t, Ek) 2 to the E~  chain from B10.D2.  Although 
the  EO  chain  from  the  F1  animals  (presumably  encoded  by  the  D2.GD  parental 
chromosome in the F1) was quite similar to the E~ chain from B10.D2, they were not 
identical.  This  result  was  not  expected  because  D2.GD  (H-2 ~a)  is  a  recombinant 
strain previously typed as K d Ad[Bb J b E b C b S b D b, and therefore it should possess 
the same E~ gene as B 10.D2 (H-2d). This difference between the E a chain encoded by 
the D2.GD genome and other bona fide E~ chains was also noted by Jones  (6), who 
used two-dimensional  (2D) electrophoresis to document the difference. 
Two obvious and mutually exclusive hypotheses may be put forward to explain the 
aberrant  nature of the E~ chain from D2.GD. The first of these is that the recombi- 
national  event  in  D2.GD  occurred not  between  the I-A  and  the I-B subregions,  as 
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Jones and her co-workers  originally used the designation A, to denote the I-A subregion location of this 
gene. We will use the E  a notation because the gene product, the Ep chain is part of the I-E antigen. 
2 Strain D2.GD, like all I-E  b type strains, does not contain a functional E~ gene, whereas the I-A t region 
of A.TFR5 does not contain a functional E~ gene. Thus,  (D2.GD x  A.TFR5)F1 animals express only a 
k  d  single I-E antigen produced by trans complementation of the Eo and E~ genes. 
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previously indicated,  but rather within the E# gene within the I-A subregion. Alter- 
natively, the previous assignment of the recombinational event in D2.GD was correct, 
and mutations have occurred within the EO gene of D2.GD, allowing it to drift slightly 
from a  true E~ gene. Data are presented in this paper that support the first of these 
two alternatives. 
Materials and Methods 
Mice.  (D2.GD X A.TFR5)Fx  mice were from the colony (CSD)  at the Mayo Clinic and 
Medical School. Mice of the BI0.D2 and B10.A(SR) strains were obtained from The Jackson 
Laboratory (Bar Harbor, ME). 
Isolation of I-E Antigens.  The a  and fl chains of I-E antigens were isolated as previously 
.....  3  described (5). Briefly, leukocytes from normal spleens were metabolically radtolabeled wxth H- 
labeled or 14C-labeled amino acids by incubation for 21 h, and, after labeling, Nonidet P-40 
(NP-40)  lysates of the cells were prepared.  The I-E antigens were isolated  by lentil  lectin 
chromatography and indirect  immunoprecipitation, using an  (A.BY ×  B10.A(18R))Ft  anti- 
B 10.A(3R) alloantiserum and Staphylococcus  aureus Cowan I strain.  Alternatively, the immuno- 
globulin-depleted NP-40 lysate was applied directly to an affinity chromatography column, 
prepared by coupling purified anti-Ia.7 monoclonal antibody (14-4-4S, produced by hybridoma 
cells generously provided by Dr. David H. Sachs, National Institutes of Health, Bethesda, MD) 
to Sepharose, followed by elution of the bound I-E antigen from the column with glycine-HC1 
(pH 2.1).  s The E,, and E# chains from the isolated I-E antigens were separated without reduction 
by preparative polyacrylamide gel electrophoresis  in sodium dodecylsulfate-containing buffers 
(SDS-PAGE). 
To~ptic Digestion and Analysis of  Peptidts.  Purified E~ and E# chains obtained from SDS-PAGE 
were reduced and alkylated and digested  with trypsin, as previously described (5). Analysis of 
tryptic peptides was by medium pressure ion exchange chromatography on a DC-6A cation 
exchange resin  (Dionex  Corp., Sunnyvale, CA) eluted with a pH 3.13 to pH 5.05 pyridine/ 
acetic acid gradient (5). 
Amino-Terminal  Amino Acid Sequence Analysis.  The Ea and Ep chains to be used for amino acid 
sequence studies  were extracted from the appropriate SDS-PAGE slices with 0.01% SDS and 
then lyophilized. The lyophilized material was redissolved in 1 ml water, dialyzed twice against 
1 liter of 0.001% SDS, and re-lyophilized.  The sample was dissolved  in 2 N formic acid and 
applied to a Beckman 890C sequencer (Beckman Instruments Inc., Fullerton, CA) for amino 
acid sequence analysis (7). 
Results 
Tryptic Peptide Comparison of the E~ Chain with the E~ Chain  from (D2.GD × A. TFRS)F1 
Hybrids.  Previous studies  of the I-E antigen  obtained  from (D2.GD  x  A.TFR5)F1 
hybrids have shown that the E~ chain contributed by the A.TFR5 parent is identical 
with the E~ chain from B10.BR(5). 
However, the E~ chain contributed by the D2.GD parent differed somewhat from 
the E~ chain from B10.D2(5). Fig. 1 shows the comparison of [14C]arginine and lysine- 
labeled tryptic peptides from B 10.D2 with the [3H]arginine and lysine-labeled tryptic 
peptides derived from the E~ chain from the D2.GD parent in the F1 hybrid. The use 
of  arginine  and  lysine  labels  allows  visualization  of  all  tryptic  peptides  in  the 
molecules, except the carboxy-terminal peptide. Although  the two profiles are quite 
similar, sharing fourteen peptides between them, there are three peptides unique to 
the E~ chain (marked by the open arrows) and one unique to theE~  chain (marked 
by the filled arrow). 
T~yptic Peptide Comparison of the E~ Chain with the E~ Chain  from (D2.GD × A. TFR5)F1 
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Hybrids.  We next compared the tryptic peptide profile from the E~ chain with that 
from the E~ chain from B10.A(5R). The rationale for this experiment was as follows: 
if the Ea chain from the g2 haplotype arises from an H-2aIH-2 b intr#genic recombi- 
national event, then those tryptic peptides that are unique to E~  t  as compared with 
E~ Should correspond to some of the peptides produced by tryptic digestion of the 
E~ chain.  Fig.  2  shows  the  comparison  of the  arginine  and  lysine-labeled tryptic 
peptides from the E~ and E~ chains. As may be seen from the figure, the E# chains 
from these two haplotypes share a number of peptides (peptide homology of ~55%) 
but,  significantly,  those  three  peptides  by  which E~  differs  from E~  are  shared 
between E~ and E~. These peptides are indicated by arrows in Fig. 2. 
Sequence Analysis of the Amino-Terminal Portion of Ep Chains. Radioehemical sequence 
analysis was carried out on E# chains metabolically radiolabeled with [3H]phenylal- 
anine. The results of the sequencer runs are presented in Fig. 3 and are summarized 
in  Table  I.  These  data  demonstrate  that  the  amino-terminal  [3H]phenylalanine 
profiles are identical for the E$ and E~  chains, and these differ from the profile for 
E~. This suggests that the amino-terminal portion of the E~  2 chain is derived from the 
d haplotypes as opposed to the b haplotype. The E k sequence (Fig. 3, panel D) from 
B 10.A(5R) is included because the Et3 chains that were sequenced contained E= chains 
at the level of ~ 10% contamination. (In panels A-C, compare the size of the peaks at 
step 8 with the heights of the peaks at step  12.) All assigned phenylalanine positions 
are from peaks that fit a single repetitive yield line (~92%). These data support the 










FIO.  1.  Ion exchange chromatography of arginine- and lysine-labeled  E~ chain from B10.D2 
(---) and from the E~ chain from (D2.GD X A.TFR5)F1 (--). The open arrows mark peptides 
unique to the E~ chain; the filled arrow marks a peptide unique to theE~ chain. See Materials and 
Methods and reference  5 for details of the method. 
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FIG. 2.  Ion exchange  chromatography  of arginine- and lysine-labled  tryptic peptides from the E~ 
chain from B10.A(5R) (---) and from theE~ chain from (D2.GD × A.TFRS)Fx (  ). The arrows 
mark the three peptides by which the E~ cha~in differs  from the E~ chain. 940  PLUNKETT  ET  AL.  BRIEF  DEFINITIVE REPORT 
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FIG.  3.  Radiocbemical  sequence analysis of the amino-terminal portions of [aH]phenylalanine- 
labeled Egkchain from (D2.GD ×  A.TFR5)F1 (A); E~ chain from BI0.D2 (B); and theE~ chain (C) 
and  the E,,  chain  (D)  from B10.A(5R).  Radioactivity  found at  each  step is  plotted  against  the 
sequencer step. See Materials and Methods and reference 7 for details of the method. 
TABLE  I 
Amino-Terminal Sequence Analysis of Ep Chains 
Strain  Chain  Sequencer steps containing phenylalanine 
(D2.GD x A.TFR5)Fi  E~  8  --*  18  27  31  --  41  -- 
B10.D2  EE~  8--18  2731--41-- 
B  10.A(SR)  f  8--18  324148 
B  10.A(SR)  E  ~  --12--222426  32--48 
* Indicates phenylalanine is absent at this position. 
contamination  by  the  E,  chain,  was  homogeneous  Ell  chain.  The  phenylalanine 
residues  identified within  positions  1-32  agree with  data  previously published  for 
E~,  E~, and  E k chains  (8-11), whereas those identified at  positions 41  and  48  (see 
Table I) have not been reported previously. 
Discussion 
Because the D2.GD  (12)  and B10.D2  (13)  strains were each derived from crosses 
involving DBA/2  (H-2d), any genetic elements with the d haplotype in these strains 
should be identical because they were derived from the same donor strain.  For the 
A d and  A~ chains  this  appears  to  be  true,  as Jones  (6)  was  able  to  demonstrate 
identical two dimensional  gel patterns  for these chains from all  three strains.  The 
analysis of the Ep chains is complicated somewhat by the fact that D2.GD will not 
express normal  amounts of the E~  chain,  and  an  Fi hybrid between  D2.GD  and 
A.TFR5 (A ''a'' E b X  A t E k) must be used to obtain usable amounts of the E~  2 chain. 
Again, Jones' two dimensional gel analysis (6) suggested that there was a difference 
in electrophoretic mobility among the Ep chains from the three strains and that the 
Ea chain derived from the D2.GD genome in the F1 hybrid was dearly different from 
the E~ chains  from B10.D2  and  DBA/2.  Furthermore, previous observations from 
one of our laboratories (14) have identified a serological difference between these Ep 
chains:  bona fide E~ chains  (such as that  from B10.D2) express a  specificity, Ia.50, 
absent from the E$  z chain. 
In our previous analysis  (5) of the E~ and Ea chains from (D2.GD ×  A.TFR5)F1 
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A.TFR5 parental chromosome, was identical to authentic E~  chains; and  (b)  the 
E~  chain,  putatively contributed  by  the  D2.GD  parental  chromosome, differed 
slightly from authentic E~ chains. As the results  presented in Figs.  1 and 2 amply 
demonstrate, the three peptides unique to the E~  z chain, when compared with the 
E~ chain, do co-elute with tryptic peptides from the E~ chain. 
There are two likely explanations for the "aberrant" E~ chain in D2.GD. The first 
is that a series of mutations have occurred within the E~ gene. This would make the 
E$  2 vs. E~ system analogous to the system of mutations observed in the H-2K  b antigen 
(15). As few as two amino acid substitutions, both of the X --4 lysine or X ---* arginine 
type, could explain the differences  observed  between the E~  and E~  profiles.  The 
second explanation is that a recombinational event occurred within the gene for the 
E~ chain. Hence, the haplotype for D2.GD should be: H-2 s~ ffi  K a, A dlb, Bb, J b, E b, 
C b, S a, D b.  We feel that the results  presented in Fig.  2 strongly support this latter 
model because it is highly unlikely that two-point mutations in the E~ gene would 
give rise to tryptic peptides that co-elute with peptides derived from theE~ gene. 
Current understanding of segmented genes for major histocompatibility complex 
molecules,  e.g.,  the eight gene segments in a  pseudogene for the H-2-1inked Qa-2 
antigen  (16), does  not  permit  one  to  say whether the crossover  event  in  D2.GD 
occurred within a coding sequence  (exon) or within an intervening sequence (intron) 
between two exons. Either of these possibilities  (both of which would be a classical 
"intragenic" recombination) would be consistent with our results, and distinguishing 
between them will require full knowledge of the genomic DNA in this region of the 
17th chromosome of D2.GD. 
We explored the genetic origin of the E~  z chain further by comparing its amino- 
terminal sequence (phenylalanines only) to that of the E~ and E~ chains. The choice 
of  labeled phenylalanine  was based on previously published (9, 10) data demonstrating 
that the positions  of phenylalanines in E~ and E~ chains were different. The results 
presented in Fig. 3 and Table I suggest that the amino-terminal portion of the E$  2 
chain, at least  up to position 48, is derived from the d haplotype. This observation, 
when coupled with the information available on the genetic origin of the other H-2 
regions of D2.GD, suggests that the orientation of the coding strand for the Ea chain 
(at least for D2.GD)  is centromerie ~  telomerie for the 5' ---* 3' reading direction. 
Recently, Rose and Cullen (17) have published a similar study using the recombi- 
nant haplotype H-2 tx to suggest that the Aa gene most likely lies to the centromeric 
side of the At~ and E# genes. These results combined with those presented here suggest 
that the gene order for the LA subregion of the H-2 complex should be (H-2K), A,, 
a~, eB... (H-2Z)). 
Summary 
The recombinant strain D2.GD was originally typed as I-A d by serological methods. 
Indeed, the Aa and A# chains of the I-A antigens appear to exhibit normal behavior 
by the criteria of serology and two dimensional gel analysis.  However, the EO chain 
encoded by the I-A subregion of this strain, one of the two components of the plasma 
membrane located I-E antigens produced in (D2.GD × A.TFR5)FI animals, has been 
demonstrated to be the product of an intragenic recombinational event between EO 
genes from the d and b haplotypes. 
Sequence analysis suggests  that  the amino-terminal portion of the E$  2 chain is 942  PLUNKETT ET AL.  BRIEF  DEFINITIVE REPORT 
derived  from the d haplotype and,  therefore,  that the coding strand  for this  gene is 
oriented  centromeric --* telomeric  (5' to 3' direction).  Finally,  these data combined 
with the data of Rose and Cullen  (17)  allow the ordering of the genes within the LA 
subregion as (H-2K), A~, AO, EO ...  (H-2D). 
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